Otolaryngol Head Neck Surg:中年高血压与晚年听力损失相关性研究

2019-08-18 AlexYang MedSci原创

最近,有研究人员调查了中年高血压与晚年听力损伤之间的相关性。研究包括了248名社区男性和女性,年龄在67岁到89岁之间,时间为2013年。研究人员从1987-1989年到2013年的5次访问研究中,每次都测量了收缩压(SBP)和舒张压。高血压通过收缩压或舒张压的提高或者抗高血压药物的使用来确定,并利用纯音听觉测量对听力进行了测量。40 dB HL截断值为临床显著性中度到重度听力损失。研究人员同时还

最近,有研究人员调查了中年高血压与晚年听力损伤之间的相关性。

研究包括了248名社区男性和女性,年龄在67岁到89岁之间,时间为2013年。研究人员从1987-1989年到2013年的5次访问研究中,每次都测量了收缩压(SBP)和舒张压。高血压通过收缩压或舒张压的提高或者抗高血压药物的使用来确定,并利用纯音听觉测量对听力进行了测量。40 dB HL截断值为临床显著性中度到重度听力损失。研究人员同时还分别考虑了0.5kHz到8kHz的5种频率听力阈值情况。在基线点,47名参与者(19%)患有高血压,183名参与者(74%)为非高血压。SBP与晚年纯音听觉均值依据测量时间而不同,SBP测量的越早,听力越差。在基线点时每10毫米汞柱SBP的纯音平均差异为1.43 dB HL(95% CI, 0.32-2.53),而在2013年为-0.43 dB HL (95% CI, -1.41-0.55)。在4种频率中(1、2、4和8kHz),基线点高血压与更高的阈值(更差的听力)相关。

最后,研究人员指出,中年时期SBP与25年后更差的听力相关。另外,高血压与听力损失进一步的纵向关系还需进一步研究。

原始出处:

Reed NS, Huddle MG, Betz J et al. Association of Midlife Hypertension with Late-Life Hearing Loss. Otolaryngol Head Neck Surg. 06 Aug 2019

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2044106, encodeId=ebe9204410626, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Jul 16 03:05:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837715, encodeId=b2c6183e71595, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Dec 04 21:05:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306411, encodeId=8b601306411d9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Aug 20 04:05:00 CST 2019, time=2019-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371498, encodeId=2a513e149801, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Aug 19 13:16:43 CST 2019, time=2019-08-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2044106, encodeId=ebe9204410626, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Jul 16 03:05:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837715, encodeId=b2c6183e71595, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Dec 04 21:05:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306411, encodeId=8b601306411d9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Aug 20 04:05:00 CST 2019, time=2019-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371498, encodeId=2a513e149801, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Aug 19 13:16:43 CST 2019, time=2019-08-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2044106, encodeId=ebe9204410626, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Jul 16 03:05:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837715, encodeId=b2c6183e71595, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Dec 04 21:05:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306411, encodeId=8b601306411d9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Aug 20 04:05:00 CST 2019, time=2019-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371498, encodeId=2a513e149801, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Aug 19 13:16:43 CST 2019, time=2019-08-19, status=1, ipAttribution=)]
    2019-08-20 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=2044106, encodeId=ebe9204410626, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Jul 16 03:05:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837715, encodeId=b2c6183e71595, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Dec 04 21:05:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306411, encodeId=8b601306411d9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Tue Aug 20 04:05:00 CST 2019, time=2019-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371498, encodeId=2a513e149801, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Aug 19 13:16:43 CST 2019, time=2019-08-19, status=1, ipAttribution=)]
    2019-08-19 orangesking

    0

相关资讯

PLoS One:普通新生儿听力筛选中永久性儿童听力损失患病率研究

永久性听力损失(PCHL)能够影响说话、语言和更多的功能。副作用事件可以通过普通新生儿听力筛选(UNHS)和早期干预来减轻。最近,有研究人员进行了一个系统性的回顾和元分析来评估UNHS检测的PCHL(双耳听力损失≥26dB HL)的患病率和新生儿重症监护室(NICU)中的变化情况。次级目的是报道UNHS计划的表现情况。研究人员鉴定了41个符合要求的报道,包括了32个群体(包括1799863筛选过的

Orphanet J Rare Dis:中国特雷切尔·柯林斯综合症家庭中TCOF1病理变异鉴定和听力重建效果研究

特雷切尔·柯林斯综合(TC,OMIM 154500)是一种颅面部发育异常的常染色体疾病,新生儿的发病率为五万分之一。尽管TCOF1、POLR1D和POLR1C已经鉴定是大约90%的TCS患者的致病基因,而8%-11%的患者的致病变异仍旧不清楚。最近,有研究人员阐释了来源于4个家庭的14名临床诊断为TCS患者的分子基础,研究人员使用的是外显子组测序(WES),并利用Sanger测序进行了鉴定。之后,

Eur Arch Otorhinolaryngol:耳鸣患者中高频畸变产物耳声发射(DPOAE)值与血液指标关系研究

最近,有研究人员调查了是否高频畸变产物耳声发射值与血小板平均体积(MPV)和中性粒细胞/淋巴细胞比值(NLR)具有正相关或者负相关关系。研究包括了52名志愿者(27名女性和25名男性),年龄在35到50岁之间且耳鼻喉科门诊诊断患有耳鸣。研究发现,在左右双耳中,4000和8000Hz气道和4000Hz骨传导途径与NLR比例呈现显著的负相关关系(P<0.05)。另外,双耳和NLRs的骨传导途径P

Int J Pediatr Otorhinolaryngol:一种新型粘着性骨传导听力设备在儿童中的首次使用研究

最近,有研究人员评估了一种新的非植入、无压力和粘着性骨传导助听器的听力益处、优势和劣势情况。研究包括了17名儿童。5名儿童患有双边传导性听力损失(CHL),6名儿童患有单边CHL,另外6名儿童患有单边感觉神经性耳聋。研究发现,在SNHL儿童中,带气泡噪音的言语测听均值为:带设备21.33 (±5.72) dB HL,不带设备为27.67 (±4.59) dB HL,且存在显著的差异(p=0.027

ORL J Otorhinolaryngol Relat Spec:年龄相关的听力损失与认知障碍关系研究

尽管年龄相关的疾病的发生率在老年人口中增加,包括老年性耳聋和认知障碍。但是两者之间的相关性仍旧未知。最近,有研究人员调查了老年性耳聋与认知障碍之间的相关性。研究包括了399名年龄不小于65岁的听力损失老年患者。研究人员使用了相关的量表进行了分析。研究发现,399名因老年性耳聋使用助听器的患者中,45名(11%)患有痴呆,354名(88.7%)不患有痴呆。当认知障碍组根据GDS评分分成轻度(1-4)

Int J Pediatr Otorhinolaryngol:非综合征听力损失家庭中MYO15A基因新的纯和变异鉴定

全世界中有数百万的人口遭受听力损失的折磨。先天性耳聋或者语前聋患者中,不少于50%的患者与遗传因子有关,并且具有高度的遗传异质性。到目前为止,尽管数百个基因在非综合征听力损失患者中已经发现,但是仍旧有许多基因或者位点需要去鉴定。最近,有研究人员利用靶标测序和Sanger测序的方法对患有常染色体阴性非综合征听力损失的哈萨克坦血统家庭进行了鉴定。之后,研究人员利用功能和结构研究来预测该新的变异造成的病